The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 18, 2020

Filed:

Dec. 17, 2015
Applicant:

Empros Pharma Ab, Solna, SE;

Inventors:

Göran Alderborn, Uppsala, SE;

Anders Forslund, Uppsala, SE;

Ulf Holmbäck, Uppsala, SE;

Hans Lennernäs, Uppsala, SE;

Jan Stefan Persson Grudén, Uppsala, SE;

Assignee:

EMPROS PHARMA AB, Solna, SE;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/20 (2006.01); A61K 9/24 (2006.01); A61K 9/28 (2006.01); A61K 31/365 (2006.01); A61K 31/702 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 9/2081 (2013.01); A61K 9/0053 (2013.01); A61K 9/209 (2013.01); A61K 9/2013 (2013.01); A61K 9/2018 (2013.01); A61K 9/2027 (2013.01); A61K 9/2054 (2013.01); A61K 9/284 (2013.01); A61K 9/2846 (2013.01); A61K 31/365 (2013.01); A61K 31/702 (2013.01);
Abstract

The present invention relates to a modified-release composition comprising orlistat and acarbose, comprising individually distinct parts with different release patterns: a) a first part, G1, comprising from about 5 to about 70% w/w of the total dose of acarbose, b) a second part, G2A, comprising from about 30 to about 95% w/w of the total dose of acarbose, c) a third part, G2B, comprising from about 10 to about 90% w/w of the total dose of orlistat, and d) a fourth part, G3, comprising from about 10 to about 80% w/w of the total dose of orlistat, and the total concentration of acarbose and orlistat, respectively, in the composition is 100% w/w.


Find Patent Forward Citations

Loading…